Back to today’s briefing

Story perspectives

Breakthrough Gene Therapy Targets KSHV Cancer in Mice

10/5/2025

30 7

Summary

Story summary

UC Davis researchers report a targeted gene therapy for Kaposi’s sarcoma–associated herpesvirus (KSHV) cancers.
The therapy uses a harmless virus to deliver a gene that activates a cancer-killing agent.
In tests, it eliminated KSHV-infected cells and halted tumor growth in mice with no side effects.
Further testing is needed before human trials, but this indicates potential for personalized cancer therapies.

1 of 1

Story summary

UC Davis researchers report a targeted gene therapy for Kaposi’s sarcoma–associated herpesvirus (KSHV) cancers.
The therapy uses a harmless virus to deliver a gene that activates a cancer-killing agent.
In tests, it eliminated KSHV-infected cells and halted tumor growth in mice with no side effects.
Further testing is needed before human trials, but this indicates potential for personalized cancer therapies.